ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,776Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 139

$1.21M Total Retail Price of All Prescriptions

Rank: 1 out of 139

518 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

15% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 13,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $83 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
ATORVASTATIN CALCIUM 805 751 1 10
LISINOPRIL 697 617 2 1
CRESTOR 551 524 3 20
LEVOTHYROXINE SODIUM 438 424 4 11
NIASPAN 432 405 5 48
MELOXICAM 359 306 6 68
SIMVASTATIN 354 335 7 5
HYDROCODONE-ACETAMINOPHEN 284 217 S3 8 2
OMEPRAZOLE 253 234 9 6
METFORMIN HCL 249 223 10 23
INDAPAMIDE 246 245 11 106
METOPROLOL SUCCINATE 229 225 12 9
GABAPENTIN 214 186 13 12
ALENDRONATE SODIUM 212 196 14 50
AMLODIPINE BESYLATE 212 209 14 3
TRAMADOL HCL 211 167 16 32
POTASSIUM CHLORIDE 202 185 17 16
ADVAIR DISKUS 197 154 18 47
FUROSEMIDE 184 184 19 4
AMIODARONE HCL 182 179 20 44
TAMSULOSIN HCL 175 168 21 14
NAMENDA 171 171 22 70
DONEPEZIL HCL 161 161 23 71
LOSARTAN POTASSIUM 160 157 24 13
MICARDIS 159 148 25 108
CARVEDILOL 158 146 26 7
CITALOPRAM HBR 155 143 27 40
WARFARIN SODIUM 151 144 28 15
PANTOPRAZOLE SODIUM 142 139 29 38
SPIRIVA 141 113 30 53
METOPROLOL TARTRATE 139 136 31 8
CLOPIDOGREL 137 126 32 29
ZOLPIDEM TARTRATE 125 85 33 24
PREDNISONE 119 106 34 39
AVODART 116 116 35 83
CELEBREX 97 96 36 195
TRAZODONE HCL 96 86 37 36
HYDROCHLOROTHIAZIDE 92 89 38 19
METHOTREXATE 90 90 39 200
AGGRENOX 90 90 39 200
DIOVAN 89 83 41 52
LANTUS 87 70 42 54
LIPITOR 87 81 42 147
BENICAR 85 85 44 74
ALLOPURINOL 85 80 44 28
NEXIUM 83 78 46 117
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 53 46 131
PLAVIX 82 78 48 45
DIGOXIN 81 79 49 37
SINGULAIR 74 60 50 76
TORSEMIDE 72 59 51 168
ATENOLOL 72 53 51 17
ISOSORBIDE MONONITRATE ER 72 65 51 18
FLUTICASONE PROPIONATE 71 59 54 42
AZITHROMYCIN 68 63 55 93
ACTOS 68 68 55 224
FINASTERIDE 67 62 57 34
FLECAINIDE ACETATE 66 51 58 89
DILTIAZEM 24HR CD 65 65 59 110
GLIMEPIRIDE 65 54 59 126
MIRTAZAPINE 65 65 59 119
ESCITALOPRAM OXALATE 63 46 62 89
BYSTOLIC 60 60 63 80
OXYCODONE HCL 56 42 S2 64 33
MORPHINE SULFATE ER 54 20 S2 65 35
PROAIR HFA 53 34 66 77
DILTIAZEM ER 52 52 67 173
OLANZAPINE 51 44 68 106
TRILIPIX 50 50 69 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.